Global Heart Organ Chip Market Growth 2025-2031

The global Heart Organ Chip market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Heart organ-on-a-chip, a microfluidic cell culture device fabricated by microchip fabrication methods, is an effective platform for drug screening and personalized therapy.

United States market for Heart Organ Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Heart Organ Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Heart Organ Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Heart Organ Chip players cover Elvesys, Emulate, TissUse GmbH, CN Bio Innovations, Mimetas, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Heart Organ Chip Industry Forecast” looks at past sales and reviews total world Heart Organ Chip sales in 2024, providing a comprehensive analysis by region and market sector of projected Heart Organ Chip sales for 2025 through 2031. With Heart Organ Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heart Organ Chip industry.

This Insight Report provides a comprehensive analysis of the global Heart Organ Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heart Organ Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heart Organ Chip market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heart Organ Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heart Organ Chip.

This report presents a comprehensive overview, market shares, and growth opportunities of Heart Organ Chip market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Give Electrical Stimulation
Give Mechanical Stimulation
Others

Segmentation by Application:
Drug Discovery
Disease Model Construction
Immune Response Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Elvesys
Emulate
TissUse GmbH
CN Bio Innovations
Mimetas
Insphero
Ascendance Bio
Axosim
Hurel
Synvivo
Nortis Bio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Heart Organ Chip market?

What factors are driving Heart Organ Chip market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Heart Organ Chip market opportunities vary by end market size?

How does Heart Organ Chip break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.